Introduction {#sec1}
============

Coronavirus-19(COVID 19) related morbidity, mortality and economic contraction has taken the world by storm since December 2019. Despite the herculean efforts directed towards curbing its transmission, the disease has continued to spread like fire.

Coronaviruses (CoVs) are zoonotic pathogens that can infect human beings by undergoing mutations.[@bib1] Air borne respiratory droplet transmission is well recognized, however alternative modes such as ocular secretions and oral-fecal route, though being held responsible for the spread in many studies are yet to be proven conclusively. [@bib2], [@bib3], [@bib4]

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike protein binds with the host cellular receptor, human angiotensin-converting enzyme (ACE)2 and gains entry into the cell in presence of transmembrane serine protease2(TMPRSS2), a cell surface associated protease. [@bib5], [@bib6], [@bib7], [@bib8] ACE2 is known to be expressed on epithelial cells in lungs, intestines and kidney.[@bib9] Recent report indicates presence of both ACE2 and TMPRSS2 in human conjunctival as well as corneal cells, making the ocular surface cells as a potential entry point and reservoir for transmission of virus.[@bib10] ^,^ [@bib11]

The mucous membrane of ocular surface is continuous from puncta via nasolacrimal duct to nasopharynx, resulting in viral transfer in either direction, even to gastrointestinal tract, if swallowed. Blood borne infection of lacrimal gland has also been proposed.[@bib12]

Inspite of the above evidence, the reported prevalence of viral RNA detection in tears varies from 0 to 7%, with higher positivity rates in severe COVID 19 patients. This has been attributed to low sensitivity of real time RT-PCR in picking up small quantities of SARS-CoV RNA, missing of window of viral shedding at the time of sample collection and a small sample size. The shedding of viral RNA in tears has been observed both in presence as well as in absence of ocular manifestations.[@bib13], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18], [@bib19]

There is inconsistency in study population in different reports, in terms of COVID-19 disease severity and lab confirmation. Also, there is variability in the method of tear sample collection that is, use of conjunctival swabs or Schirmer paper strips with separate viral transport media (VTM) for each eye. To the best of our knowledge different techniques for tear collection for SARS-CoV-2 detection have not been compared.

In the present study, to increase the yield of viral RNA in preocular tear film, sampling was done in lab confirmed hospitalized moderate and severe COVID 19 patients, using different methods, within 48 hours of collection of nasal-oropharyngeal swab and samples from both the eyes were transported in a single VTM. The objectives of this study were to investigate for the presence of SARS-CoV-2 RNA in tears of moderate to severe COVID 19 patients and ascertain the best method of tear sample collection by assessing the cycle threshold value of E gene.

Materials and methods {#sec2}
=====================

A cross-sectional study was conducted from 22^nd^ May to 4^th^ June 2020, in a one of the largest, tertiary, COVID dedicated hospitals in North India. After obtaining the institutional ethics committee clearance, the trial was registered (CTRI/2020/05/025291). Moderate and severe laboratory confirmed, adult COVID-19 cases with positive nasal-oropharyngeal RT-PCR, performed a day before, admitted in the medical block and willing to participate were enrolled in the study consecutively. Exclusion criteria included asymptomatic, mild and critical COVID-19 patients.

Moderate disease was diagnosed as those having clinical signs of pneumonia(fever, cough, dyspnoea, fast breathing ) but no signs of severe pneumonia, including Oxygen saturation (SpO2) measured by pulse oximetry \< 94% (90-94%) on room air and respiratory rate ≥24/minute. Diagnostic criteria for severe disease included clinical signs of pneumonia plus one of the following: respiratory rate \>30 breaths/min; severe respiratory distress; or SpO2 \<90% on room air.[@bib20]

In accordance with the Declaration of Helsinki, a written informed consent was taken from all the patients. A brief history and ocular examination was performed. Special attention was paid to any associated systemic co-morbidity.

The ocular samples were taken wearing full Personal protective equipment (PPE kit), within 48 hours of collection of nasal-oropharyngeal sample, from both the eyes of each patient by ophthalmologists sans topical anaesthesia. Tear samples were collected using conjunctival swabs and Schirmer paper strips.([Fig1](#fig1){ref-type="fig"} )Figure 1

For taking the conjunctival swab, the lower eye lid was retracted, the inferior fornix of the eye was swept with sterile nylon swab for 10 seconds and a similar procedure was repeated in the other eye.

When using the Schirmer paper strip (no.41 Whatman filter paper, 5mm wide and 35mm long), each strip was folded from one end and inserted at the junction of middle and outer third of the lower lid of both the eyes. The patient was asked to keep the eyes open and blink normally and after 3 minutes, the strips were removed.

In group 1, the conjunctival swabs from both eyes and Schirmer strips from both the eyes were placed in a single the viral transport media(VTM), In group 2, the conjunctival swabs from both eyes were placed in a single viral transport media(VTM) , In group 3, the Schirmer strips from both the eyes were placed in a single viral transport media(VTM).

There was two minute gap between each sampling. Each sealed and labelled VTM was further placed in a falcon tube. The falcon tube was sealed and placed in a zip lock bag and transported to the microbiology department.

Microbiological methods [@bib21]^,^[@bib22] {#sec2.1}
-------------------------------------------

All the samples were transported to the lab as soon as possible maintaining the cold chain. In case of delay the sample was stored at 4 ^0^C, not beyond 3 days. After reaching the laboratory, the samples were processed immediately or stored at -20^0^C till processing.

The real time PCR assay used the TaqMan fluorogenic probe based chemistry that used the 5 ´ nuclease activity of Taq DNA polymerase and enabled the detection of a specific PCR product as it is accumulated during PCR cycles. Coronaviruses under the subgenus Sarbecovirus that includes 2019-novel corona virus(2019-nCoV), SARS-CoV and bat SARS-like coronaviruses were used to generate a non-redundant alignment. Confirmatory assays were based on their matching to the Wuhan virus as per inspection of the sequence alignment. Suspected tear samples were first tested for E gene assay and then for confirmation RNA-dependent RNA polymerase( RdRp) and Open reading frame 1b (ORF 1b) gene assay was used.

RNA extraction {#sec2.2}
--------------

Viral RNA was extracted from all the samples (150 μl each) using the QIAamp RNA Minikit (Qiagen) according to the appropriate protocols in the manufacturer's instructions, with a final elution volume of 60 μl. Extracted RNA was stored at -20 °C until required for PCR.

Real-Time PCR {#sec2.3}
-------------

RNA extracted from all the samples was tested for the presence of SARS-CoV-2 by real time RT-PCR. Quant Studio Dx (Applied Biosystems) was used for performing the assay. The viral RNA extract and controls were amplified with primers and probes for screening for E gene and RNaseP as an internal control. Negative control (nuclease free water was used as template), positive control (Kits control) and MOCK (human source cell line) were included in each test run. Additionally, a known positive specimen was also included as an internal control during the run. Cycle conditions and PCR reagent preparation were done as per Indian Council of Medical Research (ICMR) protocol. A specimen was considered presumptive positive for 2019-nCoV, if the amplification curve for the E gene crossed the threshold line within 35 cycles. The viral load was assessed in terms of the Cycle threshold (Ct)value of the E gene. Only those samples which were positive for E gene were tested for confirmatory PCR by using Wuhan strain specific primers of the viral RdRp (RNA dependent RNA polymerase) gene and HKU -ORF sequence. A specimen was considered confirmed positive for 2019-nCoV, if the reaction growth curves crossed the threshold line within 35 cycles for E gene, and both RdRp gene and ORF gene Or either RdRp gene or ORF gene.

Statistical methods {#sec2.4}
-------------------

Paired chi- square test was used to compare the proportion of patients with positive RT-PCR in tears in laboratory confirmed moderate to severe COVID-19 cases. Average Ct value of E gene amongst the 3 groups was compared using Annova test and independent samples median test was employed to compare the medians of Ct value of E gene in tear samples positive in all three groups versus those positive in a single group. The analysis was performed using statistical software package IBM SPSS statistics 25.0(IBM, Chicago, IL)

Results {#sec3}
=======

Of the 78 cases enrolled in the study, only 75 were considered for analysis as samples of 3 patients were found inadequate for analysis. ([Table1](#tbl1){ref-type="table"} ) Thirty-six (48%) of the patients were moderate while 39(52%) were severe COVID-19 cases. There were 41 males (54.7%) and 34 females (45.3%). The ages ranged from 18 to 81 years. Fifty- six patients (74.7%) had associated systemic co-morbidity. Various co-morbidities were hypertension 42%, diabetes mellitus 41%, coronary artery disease 18%, acute/chronic kidney disease 14%, chronic lung disease/ asthma 10%, hepatitis 2.6%, B cell lymphoma 2.6%, anemia/thrombocytopenia 1.3%, rheumatic heart disease 1.3%, epilepsy 1.3%, pancreatitis 1.3%, and multiorgan dysfunction 1.3%. There were no signs or symptoms in any of the patients.Table 1Demographic details, clinical characteristics and RT-PCR results of subjectsGROUP 1GROUP 2GROUP 3C+SC+SC+SCCCSSS**S. No.AgeSexSeveritySystemic symptomsDuration (days)\*Tear C+SCt EgeneCt ORF1bCt RdRPTear CCt EgeneCt ORF1bCt RdRPTear SCt EgeneCt ORF1bCt RdRP**173Mmoderatecough, fever, SOB DM, HTN22negativenegativenegative278Fmoderatechest pain, cough CAD, HTN. DM5negativenegativenegative**368F**severe**fever, SOB DM, AKI9positive3030NDnegativenbspnbspnbspnegative478M**severe**SOB, cough COPD, HTN7negativepositive2932NDnegative5**63MmoderateFever, sore throat DM, HTN, CAD5negativenegativenegative**6**60Fmoderatefever, cough CLD6negativenegativenegative**7**27MmoderateFever, diarrhoea8negativenegativenegative**8**48Fmoderatesore throat5negativenegativenegative**9**60Fmoderatechest pain DM, HTN6negativenegativenegative**10**60FmoderateFever, headache HTN, CKD5negativenegativenegative**11**71Mmoderategeneralized weakness DM, HTN, CAD5negativenegativenegative**12**32Mseverecough, SOB, fever Asthma6negativenegativenegative**13**67Mseverecough, SOB, fever DM, HTN, CAD7negativenegativenegative**14**51Fmoderatediarrhoea, vomiting, fever HTN, depression7negativenegativenegative**15**20MmoderateFever, vomiting, Acute viral hepatitis with pancreatitis5negativenegativenegative**16**35fsevereDM, HTN, RHD (Severe MS)4negativenegativenegative**1735F**moderate**Fever, vomiting5negativepositive2930NDnegative1866M**moderate**Fever, vomiting seizure disorder3negativenegativepositive**3335ND**19**30MsevereCough, SOB5negativenegativenegative**20**55MmoderateFever, cough, SOB DM, HT, active TB15negativenegativenegative**21**44MmoderateFever8negativenegativenegative**2218M**moderate**Fever, vomiting Anaemia, thrombocytopenia4negativenegativenegative23**61FsevereFever, SOB HTN5negativenegativenegative**24**64Mmoderatecough, sore throat DM, HTN, CAD8negativenegativenegative**25**45MsevereSOB, Bodyache, dizziness DM4negativenegativenegative**2660M**severe**SOB DM4negativepositive3332NDnegative27**66Fseverecough, SOB, fever DM, HTN7negativenegativenegative**28**58Mseverefever, cough, SOB DM, HTN, CAD11negativenegativenegative**29**73FsevereSOB COPD4negativenegativenegative**30**74MsevereSOB,Fever, cough4negativenegativenegative**3162M**severe**Fever,cough, SOB DM8positive222223positive232322positive28272732**21Fseverecough5negativenegativenegative**3363M**severe**SOB, fever DM4positive3433NDnegativenegative3423F**moderate**SOB, Fever DM, HTN, COPD5negativepositive34ND32negative35**60FsevereCough, SOB HTN, DM5negativenegativenegative**36**52MmoderateChest pain HTN, CAD4negativenegativenegative**3768F**severe**fever, cough CKD, DM, HTN8Positive2526NDPositive3032NDpositive3535ND38**66Mmoderatecough, SOB DM, HTN6negativenegativenegative**3980M**moderate**SOB MODS with AKI4Positive2627NDPositive2928NDPositive2828ND4055M**moderate**cough, fever B cell lymphoma5Positive141618Positive151618Positive1516184133M**severe**SOB CKD4Positive3232NDPositive3128NDPositive2627ND42**20MmoderateSOB CKD4negativenegativenegative**43**60Fseverefever, cough, SOB CKD5negativenegativenegative**4449F**moderate**Fever, SOB5Positive3434NDnegativenegative45**51FsevereFever, SOB, vomiting DM, CKD8negativenegativenegative**46**34MmoderateCough, sore throat, chest pain DM, HTN, CAD4negativenegativenegative**47**53FmoderateSOB HTN, CKD8negativenegativenegative**48**60FsevereSOB, cough , fever Asthma7negativenegativenegative**49**47FsevereDiarrhoea HTN, CKD5negativenegativenegative**50**78FmoderateFever DM, HTN, CAD7negativenegativenegative**51**75Fseverecough, SOB7negativenegativenegative**5258M**severe**SOB DM, CAD5positive3334NDnegativenegative53**40MmoderateFever, SOB21negativenegativenegative**5473M**severe**SOB, fever smoker9positive3131NDnegativenegative55**62MmoderateSOB Hodgkin\`s lymphoma4negativenegativenegative**56**44Mseverecough, SOB DM6negativenegativenegative**57**81Fmoderatefever, cough, SOB DM, HTN, CAD14negativenegativenegative**58**63FmoderateFever, SOB, cough DM, HTN8negativenegativenegative**59**48Mmoderatecough HTN, CKD3negativerejectednegative**60**50Fseveresore throat, fever, SOB5negativenegativenegative**61**73Fseverecough, SOB HTN, CKD4negativenegativenegative**62**57Mmoderatefever HBs Ag positive4negativenegativenegative**63**56Mseverefever, cough, SOB B/L pneumonitis11negativenegativenegative**64**47MsevereSOB, cough , fever CKD9negativenegativenegative**65**60Fseverecough, SOB, fever COPD7negativerejectednegative**66**48MsevereFever, cough, SOB DM, HTN, AKI8negativenegativenegative**67**60MmoderateFever, sore throat, cough DM, HTN8negativenegativenegative**68**62FsevereFever, cough, SOB HTN7negativenegativenegative**6980F**severe**Fever, cough, SOB18negativepositive3233NDnegative70**62Fmoderatefever, cough DM5negativenegativenegative**71**72MsevereSOB HTN, Old TB7negativenegativenegative**72**72Fseverefever, cough, SOB8negativenegativenegative**73**43Mseverefever, cough, SOB, bodyache8negativenegativenegative**74**57MmoderateSOB, fever, sore throat , cough21rejectedrejectedrejected**75**57Fseverecough, nasal discharge HTN, CAD8negativenegativenegative**7660F**severe**SOB, cough, fever, chest pain, abdominal pain HTN9positive3130NDnegativenbspnbspnbsppositive3030ND7760M**moderate**backache DM, CAD, Pulmonary HTN, CLD2negativepositive3432NDnegative78**35Mmoderatefever, cough, SOB14negativenegativenegative[^1][^2]

Out of 75 patients, RT-PCR was positive in tears of 18 patients (24%). The mean age of patients with positive RT-PCR in tears was 56.78± 16.79 years (p=0.56). All except 3 of the patients with positive RT-PCR in tears, had associated systemic co-morbidities with 6 having more than one co-morbidity.

Twenty-nine out of 225 (12.9%) samples of 75 patients were positive. The positive samples in group 1(conjunctival swab +Schirmer's paper strip), group 2 (conjunctival swab) and group 3 (Schirmer's paper strip) were 11 (14.7%), 11 (14.7%) and 7 (9.3%) respectively (p=0.3105)

The mean Ct values of E gene in group 1, 2 and 3 were 28.36±6.15, 29.00±5.58 and 27.86±6.46(p=0.92).([Fig 2](#fig2){ref-type="fig"} ) Five patients had positive RT PCR by all the three methods, the mean Ct values of E gene of these patients was 25.24±6.33. (Fig.S, available at <http://www.aaojournal.org>). The Ct value of E gene greater than 26 was observed in 9 out of 11 positive samples (p=0.00, Kappa=0.27) in group 1 and 2; 5 out of 7 positive samples (p=.000, Kappa=0.42) in group 3. In 12 patients, positive results were obtained by either of the 3 methods (6 patients in group 2, 5 patients in group 1 and 1 patient in group 3), the mean Ct value being 32.16±1.94. The difference in Ct values in patients with positivity in all 3 groups as compared to positivity in a single group (conjunctival swab +Schirmer strip/ conjunctival swab / Schirmer strip) was statistically significant (p=0.029). Only in 1 patient, samples were positive in 2 groups (conjunctival swab +Schirmer strip and Schirmer strip). ([Table 2](#tbl2){ref-type="table"} )Figure 2Table 2Relationship of mean Ct value of E gene with positivity of RT-PCR in tears in different groupsPositive tear samplesNumber of patientsMean Ct value(E gene)All 3 methods525.24Single method1232Two methods130.5

The median value of the number of days from onset of symptoms to collection of tear samples in patients with positive RT-PCR in tears was 5 days (4 to 9 days). ([Fig 2](#fig2){ref-type="fig"})

Discussion {#sec4}
==========

The role of ocular surface as a possible portal of entry, reservoir for replication and transmission of SARS-CoV-2 RNA has been extensively explored.[@bib9] ^,^ [@bib23], [@bib24], [@bib25] Difference in detection of viral RNA in tears has ranged from 0 to 7 % with some researchers claiming minimal viral shedding in ocular secretions. [@bib13], [@bib14], [@bib15], [@bib16], [@bib17], [@bib18], [@bib19] Recently, live virus has been demonstrated in ocular fluids by demonstrating cytopathic effect in Vero E6 cells. [@bib26] Though initial reports had included asymptomatic, mild and clinically suspected COVID-19 cases, it was noticed that both the patients showing positive RT-PCR in tears were critical COVID-19 patients.[@bib15]

Sample collection has been described using conjunctival swab and Schirmer paper strip. [@bib3] ^,^ [@bib13], [@bib14], [@bib15] ^,^ [@bib17], [@bib18], [@bib19] To the best of our knowledge, in the published literature, either the precorneal tear film of a single eye was tested, or in case of bilateral tear collection, the samples were transferred in separate VTMs from each eye. The diagnostic sensitivity of the precorneal tear film could possibly be marred by the insufficient sample volume. [@bib27]

To overcome the lack of uniformity in the study populations in the available studies, we exclusively included adult moderate and severe COVID-19 cases with positive nasal-oropharyngeal RT-PCR. The quantity of ocular sample was increased by inoculation of tears from both the eyes in a single VTM. The viral load is known to fall in the second and third week of symptoms[@bib23], therefore the ocular sampling was performed within 48 hours of confirmatory nasal-oropharyngeal swab. Conjunctival swab has been considered the gold standard for tear collection and evaluation of viral RNA. To determine the best method for collection of tears, we used the methods previously described namely conjunctival swab (group2) and Schirmer paper strip (group 3), along with a combination of conjunctival swab with Schirmer strip (group 1).

In our study, 18 out of 75 patients (24%) had positive RT-PCR in tears by at least one of the methods. The closest to this outcome is a report from Iran, where positive tear samples were found in 3 out of 30 (10%) severe, laboratory confirmed COVID-19 patients, the additional 13 subjects in their study had a negative nasopharyngeal swab [@bib18]. In a retrospective analysis of 38 patients from Hubei, only 28 cases had a positive RT-PCR in nasopharyngeal swab, 4 of which were moderate, 2 were severe and 6 were critical COVID-19 cases. Tears were positive for viral RNA in 2 critical COVID-19 cases (7%).[@bib15]

In 121 patients from a study in Wuhan, only 3 (2.4%) had positivity in tears of which 52.1% were mild to moderate and 47.9% were severe or critical COVID-19 laboratory confirmed cases. [@bib14]

Only a single case had a positive conjunctival swab out of 45 (2.23%) in an Indian study. However, their subjects included 14 asymptomatic cases, including the case with positive RT-PCR in tears. [@bib19]

Seah et al did consecutive sampling in 17 patients but did not detect viral RNA in any of the tear samples. However, 52 out of 64 samples in their study were collected in the second and third week of onset of symptoms.[@bib3] In a cross-sectional study by Zhang et al, out of 102 COVID-19 cases only 1 had tear positivity. Their average time of sample collection 18.15 days, ranging from 6 to 46 days. [@bib28]

In our series, the tear samples showing positive results had been collected from 4^th^ to 9^th^ day, with median value being 5^th^ day from onset of symptoms.

Ocular manifestations due to COVID-19 have been observed along with other clinical features. Patients have also presented solely with Conjunctivitis and keratoconjunctivitis. [@bib29] ^,^ [@bib30] Zhou et al reported ocular symptoms in 8 out of 121(6.6%) patients, in the form of itching 5(62.5%), redness 3(37.5%), tearing 3(37.5%), discharge 2(25%) and foreign body sensation2(25%). Out of the 3 patients with positive RT-PCR in tears, only 1 had ocular symptoms, the remaining 2 were asymptomatic.[@bib14] In another study, 12 out of 38 patients had ocular involvement in the form of conjunctival hyperemia, chemosis, epiphora and increased secretions, of which 2 showed positivity in tears. [@bib15] Karimi et al in their series of 43 patients observed that out of the 3 patients with positive tear samples, 1 had conjunctivitis, 1 had foreign body sensation and the third was asymptomatic.[@bib18] Citing a low viral load in non-inflamed tissues, ocular involvement has been suggested as a pre-requisite for viral shedding in tears. [@bib13] The absence of ocular signs and symptoms, in any of the tear positive cases, in our series and also by others implies that viral shedding in tears is not always related to ocular inflammation as proposed previously. [@bib14] ^,^ [@bib18] ^,^ [@bib19] Collection of tears and analysis of viral RNA from both eyes probably lead to increased yield though there were no ocular abnormalities.

Most of the researchers have used conjunctival swabs for tear collection except Seah et al who used Schirmer paper strip. [@bib3] ^,^ [@bib13], [@bib14], [@bib15] ^,^ [@bib17], [@bib18], [@bib19] In our study equal number of samples were positive in group 1 and group 2. The number of positive samples in group 3 were less than that in group 1 and group 2, though statistically insignificant. This implied that use of conjunctival swab alone is justified for tear collection.

The viral load in tears can be indirectly assessed by the Ct value of the E gene. It was observed that if the Ct value of E gene was less, the viral RNA could be detected by all the three methods. Probably in cases with severe viremia early in the course of the disease, there occurs high viral shedding in tears, reflected by low Ct value of E gene and detection by all the three methods.

Also, in patients where only a single sample from any one group was positive, the Ct value was more than 32, and except for a single case(case 18), all were in group 1 or 2. This indicated that the viral load in the sample collected by the Schirmer strip(group3) was less and also that the ability to detect a sample with lesser viral load is more with conjunctival swab(group2) alone or in combination with Schirmer strip(group1). None of the previous studies have given the Ct value of positive tear samples till now.

There was no statistical correlation of viral shedding in tears with age of the patient or systemic co-morbidity in the present study. The efficiency of real time RT-PCR depends on adequate amounts of viral RNA in the collected sample. A high prevalence of 24% in our study, could be attributed to various factors that lead to a higher viral load in the analyzed specimen. A consistent study population of moderate to severe laboratory confirmed COVID-19 patients, collection of tear samples in the early course of disease and inoculation of samples from both the eyes in a single VTM could have contributed to the increase in detection rates.

The limitations of this study were non inclusion of mild and asymptomatic COVID-19 cases, small sample size and one- time sampling. We could not corelate the Ct values of nasopharyngeal and tear samples, due to non-availability of Ct values of nasopharyngeal swab of cases, as confirmatory nasopharyngeal real time RT-PCR had been done in many cases in some other laboratory, a day prior to admission.

To conclude, conjunctival swab is a satisfactory method of tear collection for assessment of presence of SARS-CoV-2 by RT-PCR. The respiratory tract is not the only transmission route and considerable viral shedding occurs in the pre corneal tear film in moderate to severe COVID 19 cases, thus implying that besides N95 respirators, use of goggles and face shields by health care workers should be mandatory when handling moderate to severe COVID-19 patients to reduce the transmission of SARS-CoV-2.

Funding {#sec5}
=======

Nil

Precise {#appsec2}
=======

SARS CoV-2 viral RNA was detected in tears of 24% of laboratory proven moderate to severe COVID 19 patients, in early course of the disease, posing risk of viral transmission through tears.
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[^1]: Ct value of E gene is mentioned for only those patients whose tear film sample was positive for SARS-CoV-19

[^2]: Abbreviations: ND- Not detectable, OB - Shortness of Breath, DM - Diabetes Mellitus, HTN - Hypertension, CAD - Coronary Artery Disease, RHD - Rheumatic Heart Disease, MS - Mitral Stenosis, AKI - Acute Kidney Injury, CKD - Chronic Kidney Disease, CLD - Chronic Liver Disease, **\* Duration of onset of symptoms till collection of sample,**
